ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

House Members Who Voted for Veto

January 3, 1986

ASCO Urges Doubling Cooperative Group Program Budget

April 16, 2010

Stronger Measures Needed To Reduce U.S. Smoking, IOM Says.

June 1, 2007

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001